| JYHB2100105 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2021-02-02 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2021-03-09 | view |
| JYHB2100088 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2021-01-22 | Pharmacyclics LLC | Pharmacyclics Inc | In Review | 2021-01-21 | view |
| JYHB2001826 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-09-19 | Pharmacyclics LLC | Pharmacyclics Inc | In Review | 2020-09-18 | view |
| JYHB2000345 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-04-10 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2020-06-12 | view |
| JYHB2000627 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-05-25 | Pharmacyclics LLC | Pharmacyclics Inc | Filed | 2020-06-04 | view |
| JYHB2000254 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-03-14 | Pharmacyclics LLC | Pharmacyclics Inc | Filed | 2020-03-26 | view |
| JYHB1900651 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(2.4) | Supplementary Application | 2019-06-03 | Janssen Research & Development, LLC | Janssen Research & Development LLC | In Review | 2019-06-01 | view |
| JYHB1900652 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(2.4) | Supplementary Application | 2019-06-03 | Janssen Research & Development, LLC | Janssen Research & Development LLC | In Review | 2019-06-01 | view |
| JYHB1900203 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2019-02-22 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2019-04-04 | view |
| JYHB1800207 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2018-03-05 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-11-09 | view |
| JXHL1800070 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2018-06-28 | Janssen Research & Development, LLC | Janssen Research & Development LLC | Certificate Issued | 2018-10-16 | view |
| JYHB1701213 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2017-09-26 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-07-06 | view |
| JYHB1701174 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2017-09-18 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-04-18 | view |
| JXHL1700019 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2017-02-17 | Janssen Research & Development, LLC | Janssen Research & Development LLC | Certificate Issued | 2017-11-08 | view |
| JYHB1701171 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2017-09-11 | Pharmacyclics LLC | Pharmacyclics Inc | Filed | 2017-09-25 | view |
| JXHS1600066 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.1) | Import Drug Application | 2016-11-07 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2017-08-28 | view |
| CXHL1502219 | 依鲁替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(3.1) | New Drug Application | 2016-03-11 | 哈尔滨珍宝制药有限公司 | Harbin Zhenbao Pharmaceutical Co Ltd | Certificate Issued | 2017-03-15 | view |
| CXHL1502218 | 依鲁替尼 | ibrutinib | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2016-03-11 | 黑龙江珍宝岛药业股份有限公司鸡西分公司 | Jixi Branch of Heilongjiang Zhenbaodao Pharmaceutical Co Ltd | Certificate Issued | 2017-03-15 | view |
| CXHL1502113 | 依鲁替尼 | ibrutinib | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2016-02-25 | 上海汇伦江苏药业有限公司 | Shanghai Huilun (Jiangsu) Pharmaceutical Co Ltd | Certificate Issued | 2017-03-07 | view |
| CXHL1502114 | 依鲁替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(3.1) | New Drug Application | 2016-02-25 | 上海汇伦江苏药业有限公司 | Shanghai Huilun (Jiangsu) Pharmaceutical Co Ltd | Certificate Issued | 2017-03-07 | view |
